Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...

Deflation or Inflation: Gold Doesn't Care

Rudi Fronk and Jim Anthony, cofounders of Seabridge Gold, discuss recession, central bank panic and an outrageous gold price. In our view, gold investors should settle back with some popcorn and enjoy the coming fireworks, which will include the best gold bull market ...

Analyst: Acquisition by Colorado-Based Specialty Pharma 'Could Bolster Revenue 400%'

The benefits and terms of the agreement are outlined in a Ladenburg Thalmann report. In a Sept. 18 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Aytu BioScience Inc. (AYTU:NASDAQ) signed a definitive agreement to acquire Innovus Pharmaceutic...

Biopharma 'Keeps Executing and Securing Milestones'

The company's latest achievement and partnership potential are addressed in a ROTH Capital Partners report. In a Dec. 12 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that Daré Bioscience Inc. (DARE:NASDAQ) received U.S. Food and Drug Adminis...

Trump Impeached in the House! Is It Time for Gold Now?

Last week, the House voted to impeach Donald Trump. This is the third time in the U.S. history such an event has happened to the sitting President. What does it imply for the gold market? Trump’s Impeachment, Explained On Wednesday, the House of Represe...

Biotech Announces Deal with Bayer on Non-Hormonal Contraception

Details of the arrangement and an update on the company's pipeline are provided in a Dawson James report. In a Jan. 13 research note, Dawson James Securities analyst Jason Kolbert reported that Daré Bioscience Inc. (DARE:NASDAQ) partnered with Bayer, the company beh...

E*Trade Financial (ETFC): Will the stock run into an options wall?

Online brokerage house E*Trade Financial Corporation ( NASDAQ: ETFC , Stock Forum ) announced on Friday that Chief Financial Officer Bruce Nolop will step down from his post at the end of the year. Nolop, who has served as CFO since 2008, will be succeeded by Matthew Aude...

Yingli Green Energy (YGE): Can it remain in double-digit territory?

Chinese stocks were in focus on Monday, after a surprise rate hike out of Beijing. As a result, options players swarmed the shares of Yingli Green Energy ( NYSE: YGE , Stock Forum ), with speculators revealing a preference for front-month, out-of-the-money strikes. By M...

And Here Comes Whirlaway!: What Silver and the Horse Have in Common

Sector expert Michael Ballanger anticipates the come-from-behind winning run of silver. In the late 1930s, a young stallion was born in Lexington, Ky., at the legendary Calumet Farm, that went on to win seventeen major races from 1940–1942, including the Triple Crown (Kent...

NexTech AR Solutions Update After Major Ramp-Up

Technical analyst Clive Maund provides an update on the prospects for this technology firm. While clivemaund.com is primarily a resource stocks website, we recognize that investing is an opportunity cost game, and for this reason we have no problem buying a tech stock...
1 2 3